Explore the words cloud of the In-Cytes project. It provides you a very rough idea of what is the project "In-Cytes" about.
The following table provides information about the project.
MAXWELL BIOSYSTEMS AG
|Coordinator Country||Switzerland [CH]|
|Total cost||135˙500 €|
|EC max contribution||135˙500 € (100%)|
1. H2020-EU.184.108.40.206. (Enhancing the innovation capacity of SMEs)
|Duration (year-month-day)||from 2019-10-15 to 2020-10-14|
Take a look of project's partnership.
|1||MAXWELL BIOSYSTEMS AG||CH (ZURICH)||coordinator||135˙500.00|
MaxWell Biosystems AG (MxW) is a Swiss public limited company (AG) who developed electrophysiological platforms (hardware-software-bioassays) for basic research and drug testing on nerve cells. MxW’s aim is to develop In-Cytes, a radically innovative electrophysiology platform to assess neural connectivity for preclinical drug discovery for brain diseases. In contrast to the state-of-the-art technologies for quantifying neural connectivity, which either estimate indirect connectivity or feature poor spatial resolution, In-Cytes can measure physiological direct neural intracellular connectivity among thousands of neurons. This directly addresses the industrial need in pharmacy for neural connectivity bioassays, featuring high-throughput and minimum interference with neurons’ physiology for the development of effective drugs to cure neurodegenerative disorders, such as Alzheimer’s and Parkinson’s diseases.
The proposed recruitment of an Innovation Associate will have significant impact on the business opportunities of MxW by bringing in lacking expertise for the development of In-Cytes. The envisaged grant will help to overcome the recruitment barriers of being a relatively unknown, small start-up enterprise that cannot compete with larger companies due to limited visibility, brand awareness, (perceived) career opportunities, salary and recruitment budget.
The development of In-Cytes requires the employment of an academic expert with a multidisciplinary set of skills combining knowledge in neuroscience, microfabrication and data analysis. In turn, the innovation associate will have the opportunity to become an expert in the emerging field of bio-engineering. It is in the interest of the company to continue the employment after the initial year in order to develop the first prototype of In-Cytes into an industrial end product.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IN-CYTES" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "IN-CYTES" are provided by the European Opendata Portal: CORDIS opendata.
EEN Anatolia supports to increase the innovation management capacities of SMEsRead More
ACTIVATING INCLUSIVE GROWTH IN RAILWAY SMES BY WORKPLACE INNOVATIONRead More
Peer2Scale-Health: Peer-learning action to improve innovation support to health SMEs in their scale-up processRead More